LUCY
Innovative Eyewear Inc.
NASDAQ: LUCY · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$1.05
+0.96% today
Updated 2026-04-30
Market cap
$6.49M
P/E ratio
—
P/S ratio
2.44x
EPS (TTM)
$-1.90
Dividend yield
—
52W range
$1 – $5
Volume
0.1M
Innovative Eyewear Inc. (LUCY) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $4821.00 | $56997.00 | $690670.00 | $659788.00 | $1.15M | $1.64M | $2.66M |
| Revenue growth (YoY) | — | +1082.3% | +1111.8% | -4.5% | +74.7% | +42.0% | +62.6% |
| Cost of revenue | $7735.00 | $74266.00 | $542416.00 | $716077.00 | $1.27M | $1.42M | $2.09M |
| Gross profit | $-2914.00 | $-17269.00 | $148254.00 | $-56289.00 | $-119329.00 | $215190.00 | $567451.00 |
| Gross margin | -60.4% | -30.3% | 21.5% | -8.5% | -10.4% | 13.1% | 21.3% |
| R&D | $4083.00 | $36894.00 | $86261.00 | $524692.00 | $662184.00 | $819387.00 | $725.39M |
| SG&A | $43398.00 | $316115.00 | $1.39M | $2.80M | $3.89M | $4.47M | $5.23B |
| Operating income | $-109427.00 | $-653009.00 | $-3.21M | $-5.58M | $-6.86M | $-7.92M | $-8.49M |
| Operating margin | -2269.8% | -1145.7% | -464.1% | -845.2% | -594.9% | -484.2% | -319.2% |
| EBITDA | $-109427.00 | $-762224.00 | $-3.20M | $-5.54M | $-6.58M | $-7.62M | $-8.36M |
| EBITDA margin | -2269.8% | -1337.3% | -462.9% | -840.3% | -570.5% | -465.5% | -314.1% |
| EBIT | $-109427.00 | $-763218.00 | $-3.21M | $-5.58M | $-6.66M | $-7.77M | $-8.49M |
| Interest expense | $0.00 | $4966.00 | $39433.00 | $105171.00 | $3036.00 | $0.00 | — |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-109427.00 | $-768184.00 | $-3.24M | $-5.68M | $-6.66M | $-7.77M | $-7.59M |
| Net income growth (YoY) | — | -602.0% | -322.4% | -75.1% | -17.3% | -16.6% | +2.3% |
| Profit margin | -2269.8% | -1347.8% | -469.8% | -861.2% | -578.2% | -474.6% | -285.2% |